The town started vaccinating inhabitants with doses in China’s Sinovac Biotech Ltd in February, also started offering the Pfizer/BioNTech vaccine in March. The authorities said it had received notice in Fosun Pharma Industrial (Hong Kong), the distributor of this Pfizer/BioNTech vaccine at the financial heart and in Macau, that packing flaws were discovered in a disease batch – numbered 210102 – associated with the closing of bottles.
“BioNTech and Fosun Pharma haven’t seen any reason to feel that product safety is in danger,” the authorities said. It was not immediately clear how many shots could be impacted, but it started using batch 210102 will be suspended, as would that of a different batch, abbreviated 210104, until further notice. Macau’s Department of Health said on Wednesday that it was suspending production of this BioNTech vaccine at the neighboring particular administrative area after finding a packaging defect.
Hong Kong on Wednesday temporarily suspended COVID-19 vaccinations with two batches of this remedy developed by Pfizer and BioNTech citing faulty packaging, but the authorities said producers suggested they had no reason to think safety was in danger, and also the movement was only a preventative step. On Wednesday, many centers across the Asian financial hub were advised by town governments to quit using the Pfizer/BioNTech vaccine, based on notices seen by taxpayers.